The ultimate goal of GenoRiskDx is prevention.
GenoRiskDx is a simple in-office test that uses a buccal swab specimen to obtain DNA. We handle patient specimens with the utmost care. Our detailed reports will ensure you provide your patients with the most up-to-date care and best opportunity for cancer prevention.
Insurance coverage: Medicare and most other insurers cover GenoRiskDx for people who meet their testing criteria. The Affordable Care Act (ACA, also known as ObamaCare) mandates most insurers cover breast cancer genetic test counseling and testing for women at higher risk, as well as discussion and chemoprevention for breast cancer. Colonoscopy reduces colon cancer mortality but the increased frequency (every 1-2 years) is necessary for people with high hereditary colon cancer risk.